Patrick Commiskey, MD
Ophthalmology · Albuquerque, NMNPI 1265929244
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 41 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Alcon at 30.7% of the total. Reporting peaked in 2022 at $568 and has fallen 52.4% since, to $270 in 2025.
Across 41 payments — averaging $44.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$558
- Johnson & Johnson Surgical Vision, Inc.$355
- Glaukos Corporation$201
- Carl Zeiss Meditec, Inc.$146
- Bausch & Lomb Americas Inc.$140
- Sight Sciences, Inc.$135
- plus $281 from 6 others
What the payments were for
- Food & beverage$1,817100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 15 | $558 |
| Johnson & Johnson Surgical Vision, Inc. | 6 | $355 |
| Glaukos Corporation | 4 | $201 |
| Carl Zeiss Meditec, Inc. | 1 | $146 |
| Bausch & Lomb Americas Inc. | 3 | $140 |
| Sight Sciences, Inc. | 2 | $135 |
| Aerie Pharmaceuticals, Inc. | 1 | $108 |
| AbbVie(2 entities) | 4 | $71 |
| Biotissue Holdings Inc. | 2 | $33 |
| Ivantis, Inc | 1 | $33 |
| AstraZeneca | 1 | $20 |
| Mallinckrodt Hospital Products Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARTEVO 800$146
- IOLMaster 700$146
- VERACITY SURGICAL$146
- QUATERA 700$146
- Clareon$137
- Tecnis Simplicity$115
- OMNI(R) SURGICAL SYSTEM (US)$112
- SION SURGICAL INSTRUMENT$112
- iStent inject W$109
- Rhopressa$108
- Rocklatan$108
How this compares
$1,817 in reported general payments places this provider in the 65th percentile of 81 ophthalmology providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 1,201 | $41,064 |
| Ofloxacin | 743 | $9,863 |
| Cyclosporine | 22 | $9,153 |
| MoxifloxacinMoxifloxacin Hcl | 273 | $5,070 |
| Tacrolimus | 33 | $4,182 |
| ErythromycinErythromycin Base | 209 | $2,879 |
| Ketorolac Tromethamine | 39 | $1,956 |
| Fluorometholone | 18 | $1,445 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 85 | $1,229 |
| Diclofenac Sodium | 78 | $1,098 |
| ValacyclovirValacyclovir Hcl | 33 | $1,025 |
| Doxycycline Hyclate | 23 | $707 |
| Latanoprost | 23 | $366 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 16 | $238 |
| Tobramycin | 12 | $71 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Albuquerque
- Robert MelendezAlbuquerque$349K
- John PitcherAlbuquerque$307K
- Christopher RoybalAlbuquerque$51K
- Stephen ColemanAlbuquerque$12K
- Rachel DavisAlbuquerque$10K
- Ian ThompsonAlbuquerque$10K
- Paul SanchezAlbuquerque$8K
- Iuri GolubevAlbuquerque$7K
- Thomas GilletteAlbuquerque$6K
- Kenneth DownesAlbuquerque$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.